Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jan;85(1):5-7.
doi: 10.1111/bcp.13806. Epub 2018 Nov 26.

Identifying poor adherence to antihypertensive medications in patients with resistant hypertension

Isla S Mackenzie  1 , Thomas M MacDonald  1
Affiliations
Editorial

Identifying poor adherence to antihypertensive medications in patients with resistant hypertension

Isla S Mackenzie et al. Br J Clin Pharmacol. 2019 Jan.
No abstract available

Keywords: adherence; blood pressure; hypertension; motivational interviewing; resistant hypertension; therapeutic drug monitoring.

PubMed Disclaimer

Comment on

References

    1. Avataneo V, de Nicolo A, Rabbia F, Perlo E, Burrello J, Berra E, et al Therapeutic drug monitoring guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol 2018; 84: 2535–2543. - PMC - PubMed
    1. Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, et al Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug‐resistant hypertension (PATHWAY‐2): a randomised, double‐blind, crossover trial. Lancet 2015; 386: 2059–2068. - PMC - PubMed
    1. Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J, et al High rates of non‐adherence to antihypertensive treatment revealed by high‐performance liquid chromatography‐tandem mass spectrometry (HP LC‐MS/MS) urine analysis. Heart 2014; 100: 855–861. - PMC - PubMed
    1. Gupta P, Patel P, Strauch B, Lai FY, Akbarov A, Marešová V, et al Risk factors for nonadherence to antihypertensive treatment. Hypertension 2017; 6: 1113–1120. - PubMed
    1. de Jager RL, van Maarseveen EM, Bots ML, et al Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. Br J Clin Pharmacol 2018; 84: 18–24. - PMC - PubMed

Substances